Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
34,723,329
-
Total 13F shares
-
14,016,977
-
Share change
-
+745,728
-
Total reported value
-
$1,023,203,077
-
Price per share
-
$73.00
-
Number of holders
-
80
-
Value change
-
+$55,812,836
-
Number of buys
-
62
-
Number of sells
-
17
Institutional Holders of IGM Biosciences, Inc. - Common Stock, par value $0.01 per share (IGMS) as of Q2 2020
As of 30 Jun 2020,
IGM Biosciences, Inc. - Common Stock, par value $0.01 per share (IGMS) was held by
80 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
14,016,977 shares.
The largest 10 holders included
BAKER BROS. ADVISORS LP, Redmile Group, LLC, RA CAPITAL MANAGEMENT, L.P., JANUS HENDERSON GROUP PLC, PRICE T ROWE ASSOCIATES INC /MD/, ALKEON CAPITAL MANAGEMENT LLC, BlackRock Inc., VANGUARD GROUP INC, HILLHOUSE CAPITAL ADVISORS, LTD., and Cormorant Asset Management, LP.
This page lists
80
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.